Absence of aromatase protein and mRNA expression in endometriosis
This study found no detectable aromatase protein or significant mRNA expression in various types of endometriosis lesions, challenging previous assumptions about its role in the disease.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (43)
- A predictive model for endometriosis via openalex
- Aromatase expression in endometriosis via openalex
- Aromatase expression in endometriosis. via openalex
- Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis via openalex
- Aromatase expression in endometriotic tissues and its relationship to clinical and analytical findings via openalex
- Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosis via openalex
- Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis via openalex
- Emerging drugs in endometriosis via openalex
- Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis via openalex
- Estrogen metabolizing enzymes in endometrium and endometriosis via openalex
- Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue via openalex
- Expression of Aromatase and Estrogen Sulfotransferase in Eutopic and Ectopic Endometrium: Evidence for Unbalanced Estradiol Production in Endometriosis via openalex
- Expression of Aromatase Cytochrome P450 in Eutopic Endometrium and Its Application as a Diagnostic Test for Endometriosis via openalex
- Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1 via openalex
- Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septum via openalex
- Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas via openalex
- High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome via openalex
- Increased Production of 17β-Estradiol in Endometriosis Lesions Is the Result of Impaired Metabolism via openalex
- Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis via openalex
- Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis via openalex
- Prostaglandin E<sub>2</sub>Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells<sup>1</sup> via openalex
- Steroidogenic Enzyme and Key Decidualization Marker Dysregulation in Endometrial Stromal Cells from Women with Versus Without Endometriosis1 via openalex
- Steroid receptor and aromatase expression in baboon endometriotic lesions via openalex
- Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis via openalex
- W2099423538 via openalex
- W2116022066 via openalex
- W2092174240 via openalex
- W2083288892 via openalex
- W2119982462 via openalex
- W1598892184 via openalex
- W2133456153 via openalex
- W2054034692 via openalex
- W2043029020 via openalex
- W2025393772 via openalex
- W1993354065 via openalex
- W1988258332 via openalex
- W4249014472 via openalex
- W2109525253 via openalex
- W1964185479 via openalex
Cited by (50)
- Malignant transformation of uterine serosal endometriosis to clear cell carcinoma in a postmenopausal patient: a rare case report 2026
- Endometriosis: Pathogenesis, Diagnosis and Treatment, volume II 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Hormonal Therapies before In-Vitro Fertilization in Women with Endometriosis 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- The effect of androgens on the risk of endometriosis sub-phenotypes and ovarian neoplasms: A Mendelian randomization study 2024
- Evaluation of aromatase expression in endometrioid heterotopias and endometria in patients with external genital endometriosis 2023
- Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism 2022
- Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists 2021
- Endometriosis diagnosis and medical treatment: Present and future 2021
- Changing prostaglandin E2 (PGE<sub>2</sub>) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE<sub>2</sub> receptor EP2 and EP4 2021
- Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling 2021
- Aberrant Overexpression of RNA-Editing Enzyme ADAR1 Promotes the Progression of Endometriosis 2020
- FACTORS OF ENDOMETRIAL RECEPTIVITY DOWN-REGULATION IN GENITAL ENDOMETRIOSIS 2020
- An assessment of the multifactorial profile of steroid-metabolizing enzymes and steroid receptors in the eutopic endometrium during moderate to severe ovarian endometriosis 2019
- Aldo-keto reductase 1C3—Assessment as a new target for the treatment of endometriosis 2019
- Hormonal Replacement Therapy in Menopausal Women with History of Endometriosis: A Review of Literature 2019
- Peroxisome proliferator-activated receptor-γ coactivator 1α-mediated pathway as a possible therapeutic target in endometriosis 2019
- Postmenopausal endometriosis, where are we now? 2019
- An assessment of the multifactorial profile of steroid-metabolizing enzymes and steroid receptors in the eutopic endometrium during moderate to severe ovarian endometriosis 2019
- Aromatase CYP19A1, progesterone receptor PGR and estrogen receptor ESR1 gene expression in biopsy specimens of endometrioid heterotopia and endometrial tissue by reverse transcription PCR 2019
- The impact of endometriosis on early embryo morphokinetics: a case-control study 2019
- SULFATION PATHWAYS: Contribution of intracrine oestrogens to the aetiology of endometriosis 2018
- Endometriosis after menopause: physiopathology and management of an uncommon condition 2017
- Characteristics of Women with Recurrent Endometriosis Pain after Laparoscopy and Levonorgestrel Intrauterine Device Placement 2017
- Are matrix metalloproteinases and their inhibitors reliable diagnosis biomarkers and attractive therapeutic targets in endometriosis? 2016
- Identifying biomarkers for non-invasive diagnosis of endometriosis 2016
- Molecular Biology of Endometriosis 2016
- Activin A Stimulates Aromatase via the ALK4-Smad Pathway in Endometriosis 2016
- Adenomyosis: a systematic review of medical treatment 2016
- The Endometrium in Adenomyosis 2015
- Endometriosis: alternative methods of medical treatment 2015
- Metformin Suppresses Prostaglandin E2-Induced Cytochrome P450 Aromatase Gene Expression and Activity via Stimulation of AMP-Activated Protein Kinase in Human Endometriotic Stromal Cells 2015
- Role of Aromatase Inhibitors in the Treatment of Endometriosis 2014
- An update on the pharmacological management of endometriosis 2013
- Inhibition of Type 1 17β-Hydroxysteroid Dehydrogenase Impairs the Synthesis of 17β-Estradiol in Endometriosis Lesions 2013
- Estradiol and tamoxifen enhance invasion of endometrial stromal cells in a three-dimensional coculture model of adenomyosis 2013
- Structural and molecular features of the endomyometrium in endometriosis and adenomyosis 2013
- Differential expression of steroidogenic enzymes according to endometriosis type 2013
- Estradiol and tamoxifen enhance invasion of endometrial stromal cells in a three-dimensional coculture model of adenomyosis 2013
- Endometriosis – Pathogenesis, Diagnosis, and Therapeutic Options for Clinical and Ambulatory Care 2013
- Role of Inflammation and Aromatase Expression in the Eutopic Endometrium and its Relationship with the Development of Endometriosis 2012
- Progesterone Resistance, Aromatase, and Inflammation: The Important Relationships Between Hormones and Inflammation 2012
- The Endometrium in Adenomyosis 2012
- Endometriosis in menopause: a single institution experience 2012
- Hormonal strategy for the primary or secondary treatment of endometriosis 2012
- Effects of progestins on local estradiol biosynthesis and action in the Z-12 endometriotic epithelial cell line 2012
- Endométriose : pourquoi se développe-telle ? 2012
- Macrophage Migration Inhibitory Factor Is Involved in a Positive Feedback Loop Increasing Aromatase Expression in Endometriosis 2012
- Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model 2011
Source provenance
- europepmc
- last seen: 2026-09-15T06:16:59.523076+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:05.573375+00:00